← FDA Drug Approvals (Drugs@FDA)

TERBUTALINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AREVA PHARMS · Approved 2013-11-08

Drug application

FDA Application #

ANDA200122

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERBUTALINE SULFATE

Generic name

Terbutaline Sulfate

Active ingredients

TERBUTALINE SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

AREVA PHARMS

First approval

2013-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown